PubRank

E Aizenman

Author PubWeight™ 54.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of the relA1 mutation and a comparison of relA1 with new relA null alleles in Escherichia coli. J Biol Chem 1989 2.46
2 The nucleotide sequence and characterization of the relA gene of Escherichia coli. J Biol Chem 1988 2.45
3 Overexpression of the relA gene in Escherichia coli. J Biol Chem 1991 2.33
4 rexB of bacteriophage lambda is an anti-cell death gene. Proc Natl Acad Sci U S A 1998 1.95
5 p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J Neurosci 2001 1.74
6 Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci Lett 1989 1.46
7 Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 1997 1.46
8 The regulation of the Escherichia coli mazEF promoter involves an unusual alternating palindrome. J Biol Chem 2000 1.37
9 Apoptotic surface delivery of K+ channels. Cell Death Differ 2006 1.31
10 NMDA receptor-mediated neurotoxicity: a paradoxical requirement for extracellular Mg2+ in Na+/Ca2+-free solutions in rat cortical neurons in vitro. J Neurochem 1997 1.21
11 Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits. J Pharmacol Exp Ther 1996 1.13
12 The modulation of N-methyl-D-aspartate receptors by redox and alkylating reagents in rat cortical neurones in vitro. J Physiol 1993 1.08
13 Laser-assisted derivation of human embryonic stem cell lines from IVF embryos after preimplantation genetic diagnosis. Hum Reprod 2007 1.06
14 Preimplantation genetic diagnosis for BRCA1/2--a novel clinical experience. Prenat Diagn 2009 1.05
15 Neural nicotinic acetylcholine responses in solitary mammalian retinal ganglion cells. Pflugers Arch 1987 1.04
16 Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 1997 1.02
17 Reverse Na+/Ca2+ exchange contributes to glutamate-induced intracellular Ca2+ concentration increases in cultured rat forebrain neurons. Mol Pharmacol 1998 1.01
18 NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro. J Neurosci 2000 0.97
19 The interaction of agonists and noncompetitive antagonists at the excitatory amino acid receptors in rat retinal ganglion cells in vitro. J Neurosci 1988 0.97
20 Enhancement of NMDA receptor-mediated currents by light in rat neurones in vitro. J Physiol 2000 0.93
21 The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience 1994 0.92
22 Botulinum toxin prevents stimulus-induced backfiring produced by neostigmine in the mouse phrenic nerve-diaphragm. J Physiol 1986 0.89
23 Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. J Neurosci 2000 0.88
24 Nitric oxide modulates NMDA-induced increases in intracellular Ca2+ in cultured rat forebrain neurons. Brain Res 1992 0.87
25 Functional expression of muscle-type nicotinic acetylcholine receptors in rat forebrain neurons in vitro. Methods Find Exp Clin Pharmacol 2002 0.87
26 Nicotinic antagonists enhance process outgrowth by rat retinal ganglion cells in culture. Science 1988 0.87
27 Characterization of nicotinic receptors in chick retina using a snake venom neurotoxin that blocks neuronal nicotinic receptor function. J Neurosci 1989 0.87
28 A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity. Neuroscience 2006 0.87
29 Dihydrokainate-sensitive neuronal glutamate transport is required for protection of rat cortical neurons in culture against synaptically released glutamate. Eur J Neurosci 1998 0.86
30 A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors. J Pharmacol Exp Ther 1999 0.86
31 Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons. Eur J Pharmacol 1997 0.86
32 Allosteric modulation of the NMDA receptor by dihydrolipoic and lipoic acid in rat cortical neurons in vitro. Neuron 1993 0.85
33 N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J Neurosci 1991 0.85
34 The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site. J Neurochem 2001 0.85
35 Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801. Proc Natl Acad Sci U S A 1988 0.84
36 Pentamidine is an N-methyl-D-aspartate receptor antagonist and is neuroprotective in vitro. J Neurosci 1992 0.83
37 Reduction of NMDA receptors with dithiothreitol increases [3H]-MK-801 binding and NMDA-induced Ca2+ fluxes. Br J Pharmacol 1990 0.82
38 Oxidized glutathione modulates N-methyl-D-aspartate- and depolarization-induced increases in intracellular Ca2+ in cultured rat forebrain neurons. Neurosci Lett 1991 0.82
39 Intrinsic redox properties of N-methyl-D-aspartate receptor can determine the developmental expression of excitotoxicity in rat cortical neurons in vitro. Brain Res 1997 0.81
40 Subunit-specific interactions of cyanide with the N-methyl-D-aspartate receptor. J Biol Chem 1998 0.81
41 Stable transfection of the NR1 subunit in Chinese hamster ovary cells fails to produce a functional N-methyl-D-aspartate receptor. Neurosci Lett 1994 0.81
42 Autoradiographic localization of putative nicotinic receptors in the rat brain using 125I-neuronal bungarotoxin. J Neurosci 1991 0.81
43 Cholinergic agonist and antagonist interactions on the putative nicotinic cholinoceptor of motor neurons. Proc West Pharmacol Soc 1984 0.80
44 Long-lasting modification of the N-methyl-D-aspartate receptor channel by a voltage-dependent sulfhydryl redox process. Mol Pharmacol 1993 0.80
45 Iron-mediated oxidation of 3,4-dihydroxyphenylalanine to an excitotoxin. J Neurochem 1995 0.79
46 Inhibition by intracellular Mg(2+) of recombinant N-methyl-D-aspartate receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 2000 0.79
47 SNARE-dependent upregulation of potassium chloride co-transporter 2 activity after metabotropic zinc receptor activation in rat cortical neurons in vitro. Neuroscience 2012 0.79
48 Studies on the effects of several pentamidine analogues on the NMDA receptor. Eur J Pharmacol 1993 0.78
49 Comparison of the potency of competitive NMDA antagonists against the neurotoxicity of glutamate and NMDA. J Neurochem 1994 0.78
50 Axonal transport of alpha-bungarotoxin binding sites in rat sciatic nerve. Brain Res 1985 0.77
51 An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 1998 0.77
52 2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin. Proc Natl Acad Sci U S A 1991 0.76
53 Selective retrograde axonal transport of free glycine in identified neurons of Aplysia. Cell Mol Neurobiol 1984 0.75
54 Neuromuscular function and organotin compounds. Neurotoxicology 1984 0.75
55 Preimplantation exclusion of embryos at risk for prion diseases. Neurology 2006 0.75
56 Axonally transported alpha-bungarotoxin binding sites as a putative mechanism for motor nerve backfiring. Proc West Pharmacol Soc 1985 0.75
57 Nonenzymatic conversion of 3,4-dihydroxyphenylalanine to 2,4,5-trihydroxyphenylalanine and 2,4,5-trihydroxyphenylalanine quinone in physiological solutions. J Neurochem 1993 0.75
58 TOPA quinone, a kainate-like agonist and excitotoxin is generated by a catecholaminergic cell line. J Neurosci 1995 0.75